Ohler A - Search Results

1

MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.

Sasaki N, Murata M, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E. Sasaki N, et al. Among authors: ohler a. Circulation. 2003 Mar 4;107(8):1183-8. doi: 10.1161/01.cir.0000051457.64240.63. Circulation. 2003. PMID: 12615799 Free PMC article.

2

Activation of mitochondrial ATP-dependent potassium channels by nitric oxide.

Sasaki N, Sato T, Ohler A, O'Rourke B, Marbán E. Sasaki N, et al. Among authors: ohler a. Circulation. 2000 Feb 1;101(4):439-45. doi: 10.1161/01.cir.101.4.439. Circulation. 2000. PMID: 10653837

3

Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer.

Seharaseyon J, Ohler A, Sasaki N, Fraser H, Sato T, Johns DC, O'Rourke B, Marbán E. Seharaseyon J, et al. Among authors: ohler a. J Mol Cell Cardiol. 2000 Nov;32(11):1923-30. doi: 10.1006/jmcc.2000.1226. J Mol Cell Cardiol. 2000. PMID: 11185581 Free article.

4

Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells.

Akao M, Ohler A, O'Rourke B, Marbán E. Akao M, et al. Among authors: ohler a. Circ Res. 2001 Jun 22;88(12):1267-75. doi: 10.1161/hh1201.092094. Circ Res. 2001. PMID: 11420303

5

Evidence against functional heteromultimerization of the KATP channel subunits Kir6.1 and Kir6.2.

Seharaseyon J, Sasaki N, Ohler A, Sato T, Fraser H, Johns DC, O'Rourke B, Marbán E. Seharaseyon J, et al. Among authors: ohler a. J Biol Chem. 2000 Jun 9;275(23):17561-5. doi: 10.1074/jbc.275.23.17561. J Biol Chem. 2000. PMID: 10837494 Free article.

6

Two-photon laser scanning microscopy of the transverse-axial tubule system in ventricular cardiomyocytes from failing and non-failing human hearts.

Ohler A, Weisser-Thomas J, Piacentino V, Houser SR, Tomaselli GF, O'Rourke B. Ohler A, et al. Cardiol Res Pract. 2009;2009:802373. doi: 10.4061/2009/802373. Epub 2010 Mar 7. Cardiol Res Pract. 2009. PMID: 20224636 Free PMC article.

7

Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.

Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A, Paolocci N, Tomaselli GF, Hare JM, Kass DA. Senzaki H, et al. Among authors: ohler a. FASEB J. 2001 Aug;15(10):1718-26. doi: 10.1096/fj.00-0538com. FASEB J. 2001. PMID: 11481219

8

Electrophysiology of ion channels of the heart.

Ravens U, Wettwer E, Ohler A, Amos GJ, Mewes T. Ravens U, et al. Among authors: ohler a. Fundam Clin Pharmacol. 1996;10(4):321-8. doi: 10.1111/j.1472-8206.1996.tb00582.x. Fundam Clin Pharmacol. 1996. PMID: 8871130 Review.

9

Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.

Ohler A, Ravens U. Ohler A, et al. J Pharmacol Exp Ther. 1994 Aug;270(2):460-5. J Pharmacol Exp Ther. 1994. PMID: 7520940

10

Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block.

Ohler A, Amos GJ, Wettwer E, Ravens U. Ohler A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jun;349(6):602-10. doi: 10.1007/BF01258466. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7969512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters